Kinetics of aggrecanase- and metalloproteinase-induced neoepitopes in various stages of cartilage destruction in murine arthritis - PubMed (original) (raw)
Kinetics of aggrecanase- and metalloproteinase-induced neoepitopes in various stages of cartilage destruction in murine arthritis
J B van Meurs et al. Arthritis Rheum. 1999 Jun.
Free article
Abstract
Objective: Two major cleavage sites, one mediated by metalloproteinases (MMPs) and the other by an as-yet unidentified enzyme termed aggrecanase, have been observed in aggrecan. To learn more about the relative contribution of these enzymes during cartilage degradation, this study assessed the occurrence of both specific neoepitopes in cartilage during murine arthritis and examined the correlation between neoepitope formation and different aspects of cartilage damage.
Methods: Reversible cartilage damage was induced in mice in the zymosan-induced arthritis (ZIA) model, partly irreversible cartilage damage in the antigen-induced arthritis (AIA) model, and irreversible, destructive cartilage damage in the collagen-induced arthritis (CIA) model. Immunolocalization techniques were used to detect the specific C-terminal neoepitopes VDIPEN (MMPS) and NITEGE (aggrecanase).
Results: In normal cartilage from young adult mice, no VDIPEN epitopes were detected, but a limited amount of NITEGE epitopes were already present. During the early phase of proteoglycan (PG) depletion, NITEGE expression was raised substantially in all arthritis models. VDIPEN epitopes were not detected in this early phase of cartilage destruction. When PG depletion progressed toward advanced cartilage damage, VDIPEN epitopes were induced. During ZIA, minimal induction of VDIPEN was observed, whereas in AIA, strong, but partly reversible, VDIPEN staining was evident, and in CIA, an extensive presence and persistence of the MMP-induced neoepitope was seen. When VDIPEN epitopes were intensely present, NITEGE epitopes were greatly reduced at that site in the cartilage.
Conclusion: Presence of VDIPEN epitopes in cartilage correlated with severe cartilage damage, but these epitopes were not detected during early PG degradation. This suggests a limited role for VDIPEN-inducing MMPs in early PG degradation during murine arthritis. In contrast, aggrecanase epitopes were induced before the appearance of VDIPEN epitopes, but they disappeared with progression of cartilage damage.
Similar articles
- Cleavage of aggrecan at the Asn341-Phe342 site coincides with the initiation of collagen damage in murine antigen-induced arthritis: a pivotal role for stromelysin 1 in matrix metalloproteinase activity.
van Meurs J, van Lent P, Stoop R, Holthuysen A, Singer I, Bayne E, Mudgett J, Poole R, Billinghurst C, van der Kraan P, Buma P, van den Berg W. van Meurs J, et al. Arthritis Rheum. 1999 Oct;42(10):2074-84. doi: 10.1002/1529-0131(199910)42:10<2074::AID-ANR7>3.0.CO;2-5. Arthritis Rheum. 1999. PMID: 10524678 - VDIPEN, a metalloproteinase-generated neoepitope, is induced and immunolocalized in articular cartilage during inflammatory arthritis.
Singer II, Kawka DW, Bayne EK, Donatelli SA, Weidner JR, Williams HR, Ayala JM, Mumford RA, Lark MW, Glant TT, et al. Singer II, et al. J Clin Invest. 1995 May;95(5):2178-86. doi: 10.1172/JCI117907. J Clin Invest. 1995. PMID: 7537757 Free PMC article. - Matrix metalloproteinases and aggrecanases cleave aggrecan in different zones of normal cartilage but colocalize in the development of osteoarthritic lesions in STR/ort mice.
Chambers MG, Cox L, Chong L, Suri N, Cover P, Bayliss MT, Mason RM. Chambers MG, et al. Arthritis Rheum. 2001 Jun;44(6):1455-65. doi: 10.1002/1529-0131(200106)44:6<1455::AID-ART241>3.0.CO;2-J. Arthritis Rheum. 2001. PMID: 11407708 - Mechanisms involved in cartilage proteoglycan catabolism.
Caterson B, Flannery CR, Hughes CE, Little CB. Caterson B, et al. Matrix Biol. 2000 Aug;19(4):333-44. doi: 10.1016/s0945-053x(00)00078-0. Matrix Biol. 2000. PMID: 10963994 Review. - Articular cartilage and changes in arthritis: matrix degradation.
Mort JS, Billington CJ. Mort JS, et al. Arthritis Res. 2001;3(6):337-41. doi: 10.1186/ar325. Epub 2001 Sep 6. Arthritis Res. 2001. PMID: 11714387 Free PMC article. Review.
Cited by
- Which elements are involved in reversible and irreversible cartilage degradation in osteoarthritis?
Bay-Jensen AC, Hoegh-Madsen S, Dam E, Henriksen K, Sondergaard BC, Pastoureau P, Qvist P, Karsdal MA. Bay-Jensen AC, et al. Rheumatol Int. 2010 Feb;30(4):435-42. doi: 10.1007/s00296-009-1183-1. Epub 2009 Oct 9. Rheumatol Int. 2010. PMID: 19816688 Review. - Granulocyte-macrophage colony-stimulating factor is a key mediator in experimental osteoarthritis pain and disease development.
Cook AD, Pobjoy J, Steidl S, Dürr M, Braine EL, Turner AL, Lacey DC, Hamilton JA. Cook AD, et al. Arthritis Res Ther. 2012 Sep 20;14(5):R199. doi: 10.1186/ar4037. Arthritis Res Ther. 2012. PMID: 22995428 Free PMC article. - Urokinase, a constitutive component of the inflamed synovial fluid, induces arthritis.
Jin T, Tarkowski A, Carmeliet P, Bokarewa M. Jin T, et al. Arthritis Res Ther. 2003;5(1):R9-R17. doi: 10.1186/ar606. Epub 2002 Oct 17. Arthritis Res Ther. 2003. PMID: 12716448 Free PMC article. - Arguments for interleukin 1 as a target in chronic arthritis.
van den Berg WB. van den Berg WB. Ann Rheum Dis. 2000 Nov;59 Suppl 1(Suppl 1):i81-4. doi: 10.1136/ard.59.suppl_1.i81. Ann Rheum Dis. 2000. PMID: 11053095 Free PMC article. Review. - The accumulation of intracellular ITEGE and DIPEN neoepitopes in bovine articular chondrocytes is mediated by CD44 internalization of hyaluronan.
Embry Flory JJ, Fosang AJ, Knudson W. Embry Flory JJ, et al. Arthritis Rheum. 2006 Feb;54(2):443-54. doi: 10.1002/art.21623. Arthritis Rheum. 2006. PMID: 16447219 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources